HEADER TRANSFERASE 25-NOV-97 4PAX TITLE THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH TITLE 2 8-HYDROXY-2-METHYL-3-HYDRO-QUINAZOLIN-4-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY(ADP-RIBOSE) POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC FRAGMENT; COMPND 5 SYNONYM: PARP-CF, POLY(ADP-RIBOSE) TRANSFERASE, POLY (ADP-RIBOSE) COMPND 6 SYNTHETASE; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 CELL_LINE: SF9; SOURCE 6 ORGANELLE: NUCLEUS; SOURCE 7 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 8 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 11 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 13 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS; SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PVLPE KEYWDS TRANSFERASE, GLYCOSYLTRANSFERASE, NAD(+) ADP-RIBOSYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.RUF,G.E.SCHULZ REVDAT 5 22-MAY-24 4PAX 1 REMARK REVDAT 4 09-AUG-23 4PAX 1 REMARK SEQADV REVDAT 3 24-FEB-09 4PAX 1 VERSN REVDAT 2 01-APR-03 4PAX 1 JRNL REVDAT 1 27-MAY-98 4PAX 0 JRNL AUTH A.RUF,G.DE MURCIA,G.E.SCHULZ JRNL TITL INHIBITOR AND NAD+ BINDING TO POLY(ADP-RIBOSE) POLYMERASE AS JRNL TITL 2 DERIVED FROM CRYSTAL STRUCTURES AND HOMOLOGY MODELING. JRNL REF BIOCHEMISTRY V. 37 3893 1998 JRNL REFN ISSN 0006-2960 JRNL PMID 9521710 JRNL DOI 10.1021/BI972383S REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.RUF,J.MENNISSIER DE MURCIA,G.M.DE MURCIA,G.E.SCHULZ REMARK 1 TITL STRUCTURE OF THE CATALYTIC FRAGMENT OF POLY(AD-RIBOSE) REMARK 1 TITL 2 POLYMERASE FROM CHICKEN REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 93 7481 1996 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.JUNG,E.A.MIRANDA,J.M.DE MURCIA,C.NIEDERGANG,M.DELARUE, REMARK 1 AUTH 2 G.E.SCHULZ,G.M.DE MURCIA REMARK 1 TITL CRYSTALLIZATION AND X-RAY CRYSTALLOGRAPHIC ANALYSIS OF REMARK 1 TITL 2 RECOMBINANT CHICKEN POLY(ADP-RIBOSE) POLYMERASE CATALYTIC REMARK 1 TITL 3 DOMAIN PRODUCED IN SF9 INSECT CELLS REMARK 1 REF J.MOL.BIOL. V. 244 114 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 9296 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1170 REMARK 3 BIN R VALUE (WORKING SET) : 0.2564 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2763 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 13 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.300 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.300 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.700 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 4.400 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.800 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARAM19X.PRO REMARK 3 PARAMETER FILE 2 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 3 : NU1.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPH19X.PRO REMARK 3 TOPOLOGY FILE 2 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 3 : NU1.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: B-FACTOR DISTRIBUTION OF 1PAX WAS USED REMARK 3 AND ONLY THE OVERALL B-FACTOR WAS REFINED. REMARK 4 REMARK 4 4PAX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000179386. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NOV-96 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X31 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 180 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9296 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 15.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : 0.07500 REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.26800 REMARK 200 R SYM FOR SHELL (I) : 0.26800 REMARK 200 FOR SHELL : 7.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: X-PLOR 3.851 REMARK 200 STARTING MODEL: PDB ENTRY 1PAX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 12% PEG REMARK 280 600, 6% ISOPROPANOL, 100 MM TRIS, PH 8.5, 10 MM NU1025 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.58000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.15500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.27500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.15500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.58000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.27500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 654 REMARK 465 LEU A 655 REMARK 465 THR A 656 REMARK 465 VAL A 657 REMARK 465 SER A 658 REMARK 465 ALA A 659 REMARK 465 GLY A 660 REMARK 465 THR A 661 REMARK 465 SER A 1012 REMARK 465 LEU A 1013 REMARK 465 TRP A 1014 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 936 119.73 -166.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NU1 A 1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 HUMAN SEQUENCE NUMBERS ARE USED THROUGHOUT INSTEAD OF REMARK 999 CHICKEN NUMBERS TO FACILITATE COMPARISON WITH THE ABUNDANT REMARK 999 LITERATURE ON HUMAN PARP. SUBTRACT 3 FOR RESPECTIVE REMARK 999 CHICKEN NUMBERS. DBREF 4PAX A 654 1014 UNP P26446 PARP1_CHICK 648 1011 SEQADV 4PAX ALA A 654 UNP P26446 LYS 651 CONFLICT SEQRES 1 A 361 ALA LEU THR VAL SER ALA GLY THR LYS SER LYS LEU ALA SEQRES 2 A 361 LYS PRO ILE GLN ASP LEU ILE LYS MET ILE PHE ASP VAL SEQRES 3 A 361 GLU SER MET LYS LYS ALA MET VAL GLU PHE GLU ILE ASP SEQRES 4 A 361 LEU GLN LYS MET PRO LEU GLY LYS LEU SER LYS ARG GLN SEQRES 5 A 361 ILE GLN SER ALA TYR SER ILE LEU ASN GLU VAL GLN GLN SEQRES 6 A 361 ALA VAL SER ASP GLY GLY SER GLU SER GLN ILE LEU ASP SEQRES 7 A 361 LEU SER ASN ARG PHE TYR THR LEU ILE PRO HIS ASP PHE SEQRES 8 A 361 GLY MET LYS LYS PRO PRO LEU LEU SER ASN LEU GLU TYR SEQRES 9 A 361 ILE GLN ALA LYS VAL GLN MET LEU ASP ASN LEU LEU ASP SEQRES 10 A 361 ILE GLU VAL ALA TYR SER LEU LEU ARG GLY GLY ASN GLU SEQRES 11 A 361 ASP GLY ASP LYS ASP PRO ILE ASP ILE ASN TYR GLU LYS SEQRES 12 A 361 LEU ARG THR ASP ILE LYS VAL VAL ASP LYS ASP SER GLU SEQRES 13 A 361 GLU ALA LYS ILE ILE LYS GLN TYR VAL LYS ASN THR HIS SEQRES 14 A 361 ALA ALA THR HIS ASN ALA TYR ASP LEU LYS VAL VAL GLU SEQRES 15 A 361 ILE PHE ARG ILE GLU ARG GLU GLY GLU SER GLN ARG TYR SEQRES 16 A 361 LYS PRO PHE LYS GLN LEU HIS ASN ARG GLN LEU LEU TRP SEQRES 17 A 361 HIS GLY SER ARG THR THR ASN PHE ALA GLY ILE LEU SER SEQRES 18 A 361 GLN GLY LEU ARG ILE ALA PRO PRO GLU ALA PRO VAL THR SEQRES 19 A 361 GLY TYR MET PHE GLY LYS GLY ILE TYR PHE ALA ASP MET SEQRES 20 A 361 VAL SER LYS SER ALA ASN TYR CYS HIS THR SER GLN ALA SEQRES 21 A 361 ASP PRO ILE GLY LEU ILE LEU LEU GLY GLU VAL ALA LEU SEQRES 22 A 361 GLY ASN MET TYR GLU LEU LYS ASN ALA SER HIS ILE THR SEQRES 23 A 361 LYS LEU PRO LYS GLY LYS HIS SER VAL LYS GLY LEU GLY SEQRES 24 A 361 LYS THR ALA PRO ASP PRO THR ALA THR THR THR LEU ASP SEQRES 25 A 361 GLY VAL GLU VAL PRO LEU GLY ASN GLY ILE SER THR GLY SEQRES 26 A 361 ILE ASN ASP THR CYS LEU LEU TYR ASN GLU TYR ILE VAL SEQRES 27 A 361 TYR ASP VAL ALA GLN VAL ASN LEU LYS TYR LEU LEU LYS SEQRES 28 A 361 LEU LYS PHE ASN TYR LYS THR SER LEU TRP HET NU1 A 1 13 HETNAM NU1 8-HYDROXY-2-METHYL-3-HYDRO-QUINAZOLIN-4-ONE HETSYN NU1 NU1025 FORMUL 2 NU1 C9 H8 N2 O2 FORMUL 3 HOH *54(H2 O) HELIX 1 1 LYS A 667 ILE A 676 1 10 HELIX 2 2 VAL A 679 GLU A 688 1 10 HELIX 3 3 LEU A 698 LYS A 700 5 3 HELIX 4 4 LYS A 703 SER A 721 1 19 HELIX 5 5 GLU A 726 LEU A 739 1 14 HELIX 6 6 LEU A 755 LEU A 778 1 24 HELIX 7 7 PRO A 789 LEU A 797 1 9 HELIX 8 8 GLU A 809 ASN A 820 1 12 HELIX 9 9 GLU A 844 ARG A 847 1 4 HELIX 10 10 LYS A 849 GLN A 853 5 5 HELIX 11 11 THR A 866 GLN A 875 5 10 HELIX 12 12 VAL A 886 GLY A 888 5 3 HELIX 13 13 VAL A 901 CYS A 908 1 8 HELIX 14 14 PRO A 958 ALA A 960 5 3 HELIX 15 15 VAL A 994 GLN A 996 5 3 SHEET 1 A 5 THR A 799 VAL A 803 0 SHEET 2 A 5 TYR A 829 ARG A 841 -1 N GLU A 840 O ASP A 800 SHEET 3 A 5 VAL A 997 TYR A1009 -1 N ASN A1008 O ASP A 830 SHEET 4 A 5 ILE A 916 ALA A 925 -1 N GLU A 923 O ASN A 998 SHEET 5 A 5 ARG A 857 SER A 864 -1 N SER A 864 O LEU A 918 SHEET 1 B 4 ILE A 895 PHE A 897 0 SHEET 2 B 4 GLU A 988 VAL A 991 -1 N VAL A 991 O ILE A 895 SHEET 3 B 4 SER A 947 GLY A 950 -1 N GLY A 950 O GLU A 988 SHEET 4 B 4 MET A 929 LEU A 932 1 N TYR A 930 O SER A 947 SHEET 1 C 2 THR A 954 PRO A 956 0 SHEET 2 C 2 GLY A 974 SER A 976 -1 N ILE A 975 O ALA A 955 SHEET 1 D 2 THR A 962 LEU A 964 0 SHEET 2 D 2 VAL A 967 VAL A 969 -1 N VAL A 969 O THR A 962 SITE 1 AC1 7 HIS A 862 GLY A 863 TYR A 896 PHE A 897 SITE 2 AC1 7 LYS A 903 SER A 904 TYR A 907 CRYST1 59.160 64.550 96.310 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016903 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015492 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010383 0.00000